Upstream Manufacturing Webinars
-
Unlock The Potential Of GPEx Lightning Accelerate Your HEK Cell Line Development
3/25/2026
Discover how an advanced cell line development platform now supports HEK cells alongside CHO, enabling rapid, scalable production of complex biologics while saving up to 12 weeks on development timelines.
-
A Highly Productive, Chemically Defined Exosome Media System
3/24/2026
Explore how chemically defined media and optimized bioreactor protocols increase exosome yields 40-fold while reducing commercial manufacturing costs from $10,000 to under $1,000 per dose.
-
Flexible Therapeutic Development: Balancing Speed, Cost, and Process
3/24/2026
Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.
-
Achieving Rapid, High-Titer Expression For Next-Generation Biologics
3/24/2026
Uncover how tunable expression technology achieves optimal chain pairing and high titers for complex biologics, from four-chain bispecifics to difficult-to-express proteins, using platform processes.
-
Accelerating Vector Construction-To-IND: Achieving A 9-Month Timeline Through Integrated Cell Line Development
3/19/2026
Uncover how tighter alignment between vector construction and cell banking improved development efficiency, strengthened risk management, and enhanced early-stage program outcomes.
-
In Vitro Transcription For mRNA Production
3/13/2026
Efficient mRNA production relies on optimized IVT conditions, where NTPs, enzymes, and critical additives work together. Explore how the right components strengthen mRNA synthesis at every step.
-
Go Beyond Custom Media Screening And Prototyping
3/13/2026
Learn about manufacturing solutions that streamline cell culture media scale-up with global production capabilities, equivalency strategies, and quality assurance for reliable supply.
-
Take The Lead With The Gibco CHOvantage™ GS Cell Line Development Kit
3/13/2026
See how this kit accelerates clone development to 14 weeks with ≥7 g/L protein titers while reducing costs through royalty-free commercial licensing for therapeutic applications.
-
Extracellular Secretion Of Recombinant Proteins: Proof-Of-Principle Data
3/10/2026
Explore experimental approaches to extracellular protein secretion that streamline recovery and improve product quality. See proof-of-principle data across multiple protein types and molecular weights.
-
The Importance Of Process Locks To Align Upstream And Downstream
3/9/2026
In this closing segment from the Bioprocess Online Live event “Optimizing Process Development Through Upstream And Downstream Integration,” the panelists emphasize the importance of periodic process locks to ensure alignment between upstream and downstream development teams. These locks are critical, says Eric Doerr, a manufacturing lead at Sanofi, because they allow both upstream and downstream to have a better understanding of the process and keep them on the same page.